The "portrait" of hereditary breast cancer
- PMID: 15754129
- DOI: 10.1007/s10549-004-2172-4
The "portrait" of hereditary breast cancer
Abstract
Five to ten per cent of all breast carcinomas are of hereditary origin. Many of them have been associated to mutations in the BRCA1 and BRCA2 susceptibility genes. No "BRCA3" gene has been found to account for the non-BRCA1/BRCA2 breast cancer (BRCAx) families, and BRCAx tumors are increasingly believed to originate from multiple distinct genetic events. Phenotype studies have questioned the existence of specific "portraits" among hereditary breast carcinomas (HBC). They have shown that most BRCA1 tumors have a "basal (epithelial)-like" aspect, while BRCA2 and BRCAx HBC are more heterogeneous. HBC have also been submitted to genetic analyses, notably with the objective of resolving the heterogeneity of BRCAx lesions. The present review aims to summarize recent data on BRCA1, BRCA2, and BRCAx HBC, including hypotheses on the origin of BRCA1 tumors and their paradoxical relations to estrogen-sensitivity.
Similar articles
-
Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.Gynecol Oncol. 2005 May;97(2):457-67. doi: 10.1016/j.ygyno.2005.01.039. Gynecol Oncol. 2005. PMID: 15863145
-
Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers.J Clin Oncol. 2000 Nov 1;18(21 Suppl):107S-12S. J Clin Oncol. 2000. PMID: 11060337 Review.
-
Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.Breast Cancer Res Treat. 2008 Nov;112(2):229-36. doi: 10.1007/s10549-007-9848-5. Epub 2007 Dec 20. Breast Cancer Res Treat. 2008. PMID: 18095154
-
Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.Breast Cancer Res Treat. 2006 Jan;95(1):81-7. doi: 10.1007/s10549-005-9047-1. Epub 2005 Oct 27. Breast Cancer Res Treat. 2006. PMID: 16261400
-
The molecular pathology of hereditary breast cancer.Pathobiology. 2008;75(2):85-94. doi: 10.1159/000123846. Epub 2008 Jun 10. Pathobiology. 2008. PMID: 18544963 Review.
Cited by
-
Breast cancer in the personal genomics era.Curr Genomics. 2010 May;11(3):146-61. doi: 10.2174/138920210791110951. Curr Genomics. 2010. PMID: 21037853 Free PMC article.
-
Genetic alterations detected by comparative genomic hybridization in BRCAX breast and ovarian cancers of Brazilian population.Oncotarget. 2018 Jun 8;9(44):27525-27534. doi: 10.18632/oncotarget.25537. eCollection 2018 Jun 8. Oncotarget. 2018. PMID: 29938003 Free PMC article.
-
Biomarkers for Basal-like Breast Cancer.Cancers (Basel). 2010 May 28;2(2):1040-65. doi: 10.3390/cancers2021040. Cancers (Basel). 2010. PMID: 24281106 Free PMC article.
-
Gene therapy for carcinoma of the breast.Cancer Gene Ther. 2006 Jul;13(7):633-47. doi: 10.1038/sj.cgt.7700929. Epub 2006 Jan 6. Cancer Gene Ther. 2006. PMID: 16410823 Free PMC article. Review.
-
Identification of a p53-repressed gene module in breast cancer cells.Oncotarget. 2017 Jul 26;8(34):55821-55836. doi: 10.18632/oncotarget.19608. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915555 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous